The Street's Jim Cramer, Portfolio Manager of Action Alerts PLUS, answers viewers' Twitter questions from the floor of the New York Stock Exchange Monday. Jim's first question was whether Target's (TGT) promotion of chief financial officer John Mulligan to the new role of chief operating officer presents a buying opportunity. Jim said he was surprised by the move, and to see a new CFO appointed on the eve of Target reporting earnings is not a reason to buy. Jim noted that Action Alerts PLUS has a 'fairly substantial' position in the stock. Jim was also asked about GoPro (GPRO) at current levels, and he responded that the way to play it is through Ambarella (AMBA), because it makes chips for the GoPro cameras and other devices. He noted that it's a very highly valued stock, but that's the way to play it. Jim's third question was on SunCor Energy (SU), with a viewer wanting to know whether the stock would be much higher one year from today. Jim said he would not advise getting into the stock. Another viewer asked what was going on with Emerson Electric (EMR), and Jim responded that he was 'quite shocked' at the state of business at Emerson. He said almost every division is doing poorly, and he thinks the company just ended up being too close to oil and gas, not unlike Dover (DOV). Send your questions to @jimcramer, using the hastag #Cramerq.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.